AstraZeneca has announced the suspension of a 200 million pound investment in the research center in Cambridge, affecting 1,000 jobs.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
20:22
Railway traffic was temporarily halted between Simeria and Orăștie, after the discovery of improvised electrical installations.
20:02
Greece has moved a Patriot anti-aircraft battery to Crete for military defense against the risks of Iranian attacks on American installations.
19:41
Conflict at Amzei Pastry Shop: A man in a state of intoxication attempted to assault a woman, who defended herself with pepper spray.
19:18
Lando Norris won the Dutch Grand Prix, bringing a third consecutive victory for McLaren
19:00
China postpones the Chang'e-7 mission for the exploration of the Moon's south pole.
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
